BioNTech SE
BNTXNASDAQHealthcare● Active
$85.50
$-2.58(-2.93%)
Market Cap$21.6B
P/E Ratio—
52W High$124
52W Low$79.52
BioNTech SE（BNTX）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BNTX · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($1.09B) | ($0.68B) | $1.19B | $12.95B | $15.05B |
| Depreciation & Amort. | $0.37B | $0.30B | $0.18B | $0.12B | $0.08B |
| Stock-Based Comp. | $0.00B | $0.10B | $0.05B | $0.11B | $0.09B |
| Change in Working Capital | $0.52B | $1.22B | $5.57B | $4.52B | ($10.73B) |
| Net Cash from Operations | $0.44B | $0.21B | $5.37B | $13.58B | $0.89B |
| Investing Activities | |||||
| Capital Expenditure | ($0.17B) | ($0.45B) | ($0.71B) | ($0.36B) | ($0.15B) |
| Purchases of Investments | ($10.97B) | ($12.37B) | ($6.98B) | ($0.05B) | ($0.39B) |
| Sales of Investments | $9.14B | $10.74B | $1.19B | $0.38B | $0.00B |
| Net Cash from Investing | ($2.37B) | ($2.08B) | ($6.95B) | ($0.04B) | ($0.57B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.74B) | ($0.99B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | ($0.48B) | $0.00B |
| Debt Issued / Repaid | ($0.01B) | ($0.05B) | ($0.04B) | ($0.06B) | ($0.07B) |
| Net Cash from Financing | ($0.05B) | ($0.05B) | ($0.78B) | ($1.42B) | $0.09B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.27B | ($0.24B) | $4.67B | $13.21B | $0.74B |
| FCF Margin %(computed) | 9.79% | -8.89% | 122.18% | 76.34% | 3.88% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解BioNTech SE
关于BioNTech SE（BNTX）现金流量表
BioNTech SE 2025财年经营活动现金流$0.44B，自由现金流$0.27B（FCF利润率9.79%），资本支出($0.17B)。
常见问题
BNTX · 4 问BioNTech SE 2025财年自由现金流$0.27B，同比up210.3%。
BNTX free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10